Immunome (IMNM) Shares Issued (2020 - 2026)

Immunome (IMNM) has 7 years of Shares Issued data on file, last reported at $229000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 7.51% year-over-year to $229000.0; the trailing twelve-month figure through Mar 2026 stood at $45.3 million (up 132.76% YoY), and the FY2025 full-year result was $45.9 million, up 129.48% from the prior year.
• Shares Issued for Q1 2026 stood at $229000.0, down from $432400.0 in the prior quarter.
• Across five years, Shares Issued topped out at $125.0 million in Q2 2023 and bottomed at -$60.6 million in Q4 2023.
• The 5-year median for Shares Issued is $264500.0 (2024), against an average of $13.6 million.
• Peak annual rise in Shares Issued reached 1562.35% in 2025, while the deepest fall reached 171.0% in 2025.
• A 5-year view of Shares Issued shows it stood at $32000.0 in 2022, then slumped by 189565.62% to -$60.6 million in 2023, then soared by 126.83% to $16.3 million in 2024, then tumbled by 97.34% to $432400.0 in 2025, then tumbled by 47.04% to $229000.0 in 2026.
• The last three Shares Issued figures came in at $229000.0 (Q1 2026), $432400.0 (Q4 2025), and $44.9 million (Q3 2025), per Business Quant data.

Peer Comparison